Inventor · disambiguated record
Kodumudi S. Balaji
Also filed as: BALAJI KODUMUDI S
12 granted patents·8 pending applications·76 citations·filing 2000–2019
91Inventor score
Files withNORDSIEK MICHAEL T9GRACEWAY PHARMACEUTICALS LLC4MEDICIS PHARMACEUTICAL CORP4CHEMO RES S L2
Top patents by PatentIndex Score
20 records- 0191US8946276B2High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosisNORDSIEK MICHAEL T·Filed 2012·Granted Feb 3, 2015·15 cites·55 claims
- 0291US8299109B2Method of treating actinic keratosis with 3.75% imiquimod creamNORDSIEK MICHAEL T·Filed 2011·Granted Oct 30, 2012·17 cites·15 claims
- 0390US8222270B22×2×2 week treatment regimen for treating actinic keratosis with pharmaceutical compositions formulated with 2.5% imiquimodNORDSIEK MICHAEL T·Filed 2011·Granted Jul 17, 2012·13 cites·18 claims
- 0489US8236816B22×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimodNORDSIEK MICHAEL T·Filed 2011·Granted Aug 7, 2012·12 cites·18 claims
- 0584US9370509B22×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimodNORDSIEK MICHAEL T·Filed 2012·Granted Jun 21, 2016·5 cites·15 claims
- 0683US9072876B2Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod creamNORDSIEK MICHAEL T·Filed 2010·Granted Jul 7, 2015·7 cites·76 claims
- 0782US9642998B2Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod creamMEDICIS PHARMACEUTICAL CORP·Filed 2015·Granted May 9, 2017·3 cites·25 claims
- 0879US9198858B2Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulationsNORDSIEK MICHAEL T·Filed 2012·Granted Dec 1, 2015·3 cites·14 claims
- 0976US10238644B22×2×2 week dosing regimen for treating acting keratosis with pharmaceutical compositions formulated with 3.75% imiquimodMEDICIS PHARMACEUTICAL CORP·Filed 2016·Granted Mar 26, 2019·1 cites·20 claims
- 1072US10596155B2Aqueous-based metronidazole gel formulationsCHEMO RES S L·Filed 2019·Granted Mar 24, 2020·0 cites·14 claims
- 1169US11318130B22x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimodMEDICIS PHARMACEUTICAL CORP·Filed 2019·Granted May 3, 2022·0 cites·15 claims
- 1268US2011021555A1Lower dosage strength imiquimod formulations and shorter dosing regimens for treating actinic keratosesGRACEWAY PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 1359US2012329823A1Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal wartsNORDSIEK MICHAEL T·Filed 2012·Application pending·0 cites
- 1457US2011263636A13 x 3 x 3 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75 % IMIQUIMODGRACEWAY PHARMACEUTICALS LLC·Filed 2011·Application pending·0 cites
- 1557US2011263637A1Up to six weeks dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimodGRACEWAY PHARMACEUTICALS LLC·Filed 2011·Application pending·0 cites
- 1655US10238634B2Aqueous-based metronidazole gel formulationsCHEMO RES S L·Filed 2015·Granted Mar 26, 2019·0 cites·9 claims
- 1753US2011207766A1Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal wartsGRACEWAY PHARMACEUTICALS LLC·Filed 2010·Application pending·0 cites
- 1844US2014206735A1High dosage topical metronidazole aqueous-based gel formulations and their use to treat rosaceaMEDICIS PHARMACEUTICAL CORP·Filed 2013·Application pending·0 cites
- 1943US2011319811A1Combination therapy with cryosurgery and low dosage strength imiquimod to treat actinic keratosisNORDSIEK MICHAEL T·Filed 2011·Application pending·0 cites
- 2039US2003044432A1Acne treating compositionFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kodumudi S. Balaji files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →